For the past thirty years, Aflac Incorporated has been a steadfast ally to families confronting the unimaginable — a diagnosis of childhood cancer or a blood disorder. What began in 1995 as a heartfelt commitment has evolved into a powerful legacy of care, innovation, and hope for children and their caregivers.
To mark this 30-year milestone, Aflac leaders — including Chairman and CEO Dan Amos and Aflac Foundation President Kathelen Amos — came together with patients, survivors, doctors, and staff from the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of Atlanta. The celebration served as a moment to reflect on decades of dedication, countless lives touched, and the ongoing pursuit of better outcomes for young patients.
Among those present was cancer survivor Elaina Schreckenberger, who had appeared in an iconic photograph from the center’s first event. At just five years old, Elaina was then undergoing treatment for stage-4 neuroblastoma when a photographer captured a touching exchange between her and Dan Amos — a moment the two lovingly recreated at this year’s gathering.
Back in 1995, Amos pledged to help create what would become the Aflac Cancer and Blood Disorders Center, beginning with a $3 million donation. That initial act of generosity set in motion a philanthropic journey that has now surpassed $200 million in support for pediatric cancer and blood disorder research, care, and family assistance.
“Our work with children battling cancer and blood disorders goes far beyond corporate responsibility — it’s personal,” said Amos. “For Kathelen, our employees, and our entire sales force, it’s about ensuring no family walks this path alone. We’re committed to standing beside them, providing comfort, resources, and hope at every turn.”
Today, the Aflac Cancer and Blood Disorders Center ranks among the nation’s largest pediatric hematology and oncology programs, caring for more than 500 new cancer patients and over 2,100 new sickle cell patients each year. With a network of more than 200 clinical trials and an expert team of physicians, nurses, and researchers, the center remains at the forefront of pediatric medicine and discovery.
For Aflac and its people, true success over the past three decades is reflected not in numbers, but in the smiles of children, the relief of parents, and the strides made in advancing care. From funding breakthrough research to offering support with travel, housing, and emotional well-being, the center’s holistic model ensures that families receive care on every level.
“While thirty years is a remarkable achievement, it’s also a reminder that our mission continues,” Amos said. “We’ll keep working until every child with cancer or a blood disorder has access to healing, hope — and ultimately, a cure.”
In an era often defined by profit margins, Aflac’s three-decade journey stands as proof of what’s possible when compassion drives purpose. It’s a story not only of corporate philanthropy, but of humanity — and a promise that no child or family will face these challenges alone.
To mark this 30-year milestone, Aflac leaders — including Chairman and CEO Dan Amos and Aflac Foundation President Kathelen Amos — came together with patients, survivors, doctors, and staff from the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of Atlanta. The celebration served as a moment to reflect on decades of dedication, countless lives touched, and the ongoing pursuit of better outcomes for young patients.
Among those present was cancer survivor Elaina Schreckenberger, who had appeared in an iconic photograph from the center’s first event. At just five years old, Elaina was then undergoing treatment for stage-4 neuroblastoma when a photographer captured a touching exchange between her and Dan Amos — a moment the two lovingly recreated at this year’s gathering.
Back in 1995, Amos pledged to help create what would become the Aflac Cancer and Blood Disorders Center, beginning with a $3 million donation. That initial act of generosity set in motion a philanthropic journey that has now surpassed $200 million in support for pediatric cancer and blood disorder research, care, and family assistance.
“Our work with children battling cancer and blood disorders goes far beyond corporate responsibility — it’s personal,” said Amos. “For Kathelen, our employees, and our entire sales force, it’s about ensuring no family walks this path alone. We’re committed to standing beside them, providing comfort, resources, and hope at every turn.”
Today, the Aflac Cancer and Blood Disorders Center ranks among the nation’s largest pediatric hematology and oncology programs, caring for more than 500 new cancer patients and over 2,100 new sickle cell patients each year. With a network of more than 200 clinical trials and an expert team of physicians, nurses, and researchers, the center remains at the forefront of pediatric medicine and discovery.
For Aflac and its people, true success over the past three decades is reflected not in numbers, but in the smiles of children, the relief of parents, and the strides made in advancing care. From funding breakthrough research to offering support with travel, housing, and emotional well-being, the center’s holistic model ensures that families receive care on every level.
“While thirty years is a remarkable achievement, it’s also a reminder that our mission continues,” Amos said. “We’ll keep working until every child with cancer or a blood disorder has access to healing, hope — and ultimately, a cure.”
In an era often defined by profit margins, Aflac’s three-decade journey stands as proof of what’s possible when compassion drives purpose. It’s a story not only of corporate philanthropy, but of humanity — and a promise that no child or family will face these challenges alone.